Last reviewed · How we verify
Balovaptan therapeutic dose Treatment A
At a glance
| Generic name | Balovaptan therapeutic dose Treatment A |
|---|---|
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Constipation
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Balovaptan therapeutic dose Treatment A CI brief — competitive landscape report
- Balovaptan therapeutic dose Treatment A updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI